Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexicon Pharmaceuticals, Inc. - Common Stock
(NQ:
LXRX
)
1.690
-0.030 (-1.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexicon Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
↗
November 01, 2024
Via
Benzinga
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
↗
November 01, 2024
Via
Benzinga
Topics
Stocks
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
↗
November 01, 2024
Via
Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
↗
November 01, 2024
Lexicon Pharmaceuticals' sotagliflozin, under review as an adjunct to insulin for type 1 diabetes and CKD, faced an FDA panel vote against approval, with mixed expert support.
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock
↗
September 27, 2024
Via
Benzinga
The Analyst Verdict: Lexicon Pharmaceuticals In The Eyes Of 8 Experts
↗
September 03, 2024
Via
Benzinga
Analyst Scoreboard: 6 Ratings For Lexicon Pharmaceuticals
↗
August 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 01, 2024
Via
Benzinga
Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)
↗
October 23, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights
↗
October 17, 2024
Via
Benzinga
5 Analysts Have This To Say About Lexicon Pharmaceuticals
↗
August 02, 2024
Via
Benzinga
Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
↗
August 02, 2024
Via
Benzinga
Lexicon Pharmaceuticals: Q4 Earnings Insights
↗
March 11, 2024
Via
Benzinga
Intel Reports Weak Results, Joins Amazon, Opendoor Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
August 02, 2024
Via
Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 17, 2024
Via
Benzinga
Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
↗
June 17, 2024
Via
Benzinga
Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
↗
May 13, 2024
The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM.
Via
Investor's Business Daily
LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024
↗
May 02, 2024
LXRX stock results show that Lexicon Pharmaceuticals met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
↗
April 22, 2024
Via
Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
↗
March 27, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Via
Benzinga
Topics
Stocks
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 27, 2024
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
Via
Benzinga
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
March 12, 2024
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
Via
Benzinga
Dow Turns Higher; GDS Holdings Shares Climb
↗
March 11, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 11, 2024
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...
Via
Benzinga
Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
↗
March 11, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&P 500...
Via
Benzinga
Topics
Stocks
Top 4 Health Care Stocks You May Want To Dump In February
↗
February 15, 2024
As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 20, 2024
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Via
Benzinga
3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts
↗
January 31, 2024
If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year.
Via
The Motley Fool
3 of the Fastest-Growing Stocks on the Planet in 2024
↗
January 23, 2024
These hypergrowth stocks are expected to deliver sales growth of up to 1,106% in the new year.
Via
The Motley Fool
7 Magnificent Stocks That Can Double Your Money in 2024
↗
January 02, 2024
Triple-digit returns could be just a click of the buy button away.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
